Your browser doesn't support javascript.
loading
Association Between Renal Adverse Effects and Mortality in Patients With Hepatocellular Carcinoma Treated With Lenvatinib.
Shimamura, Yoshinosuke; Abe, Koki; Maeda, Takuto; Matsui, Takeshi; Ishiguro, Atsushi; Takizawa, Hideki.
Affiliation
  • Shimamura Y; Department of Nephrology, Teine Keijinkai Medical Center, Sapporo, Japan; shimamura-yo@keijinkai.or.jp.
  • Abe K; Department of Nephrology, Teine Keijinkai Medical Center, Sapporo, Japan.
  • Maeda T; Department of Nephrology, Teine Keijinkai Medical Center, Sapporo, Japan.
  • Matsui T; Center for Gastroenterology, Teine Keijinkai Medical Center, Sapporo, Japan.
  • Ishiguro A; Department of Medical Oncology, Teine Keijinkai Medical Center, Sapporo, Japan.
  • Takizawa H; Department of Nephrology, Teine Keijinkai Medical Center, Sapporo, Japan.
In Vivo ; 35(3): 1647-1653, 2021.
Article in En | MEDLINE | ID: mdl-33910848

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: